SARS-CoV-2 genomic characterization and evolution in ChinaResearch Article Published on 2023-08-122024-09-05 Journal: Heliyon [Category] update2024, [키워드] China Evolution genomic characterization nonpharmaceutical intervention SARS-CoV-2 [DOI] 10.1016/j.heliyon.2023.e18980 PMC 바로가기 [Article Type] Research Article
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance – VISION Network, 10 States, December 2021-August 2022Article Published on 2022-10-212022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] Against Analysis antibody antivirals B.1.1.529 benefit booster booster dose cause circulating Committee component conditions COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines dose doses Effectiveness eligible Hospitalization Hospitalized immunocompromising condition Mask moderate molecular test mRNA network nonpharmaceutical intervention offered omicron Person positive Practice predominant Prophylactic protection Protective receive recipient recommendation recommendations reduced Restricting SARS-CoV-2 therapy vaccination Vaccine variant virus [DOI] 10.15585/mmwr.mm7142a4 PMC 바로가기
Individual-based modeling reveals that the COVID-19 isolation period can be shortened by community vaccinationArticle Published on 2022-10-202022-11-16 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI approach B.1.617.2 baseline BNT162b2 vaccine booster vaccination Community Contact COVID-19 Delta Effect effective vaccine emotional Impact individual infected individual infected individuals Infection Isolation less likelihood mitigate nonpharmaceutical intervention occur outbreak profile Psychological quarantine reduce reveal risk Secondary infection subsequent sustained the patient the SARS-CoV-2 Transmission transmission of SARS-CoV-2 vaccination Vaccine-induced immunity variant Viral load [DOI] 10.1038/s41598-022-21645-y PMC 바로가기
Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses – New Vaccine Surveillance Network, United States, 2016-2021Article Published on 2022-10-072022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] accounted acute respiratory illness Adenovirus Analysis antibody-based prophylactics anticipated ARI Atypical calculate Care cause caused children circulation Clinical data clinics Community COVID-19 COVID-19 vaccine current demographic characteristics described Effectiveness eligible enrolled Enrollment estimate Health highlighting hospital Hospitalized Human rhinovirus implementation incidence Infant Infants Influenza Influenza virus Measures medical condition métapneumovirus monoclonal morbidity network New nonpharmaceutical intervention pandemic parainfluenza pathogen pathogen-specific pediatric platform proportion PROTECT respiratory respiratory syncytial virus respiratory virus risk factor RSV SARS-CoV-2 Seven severe disease Surveillance United States vaccination Vaccine virus [DOI] 10.15585/mmwr.mm7140a1 PMC 바로가기
Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021Article Published on 2022-10-032022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 진단, [키워드] 95% confidence interval acute respiratory syndrome anti-N antibody association Blood coronavirus coronavirus 2 COVID-19 COVID-19 incidence cumulative Donor effective individual Infection infections Mask mandates Mortality Multiple multivariable logistic regression nonpharmaceutical intervention Nonpharmaceutical interventions Novel coronavirus NPI NPIs reduced respiratory SARS-CoV-2 SARS-CoV-2 seroprevalence Seroprevalence Serosurvey trend United States vaccination [DOI] 10.1093/cid/ciac469 PMC 바로가기
Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods – United States, April 2020-June 2022Article Published on 2022-09-162022-11-16 Journal: Morbidity and Mortality Weekly Report [Category] SARS, 변종, [키워드] adjusted age calculated cause CDC Clinical characteristics COVID-19 COVID-19 hospitalization database deaths Delta early treatment Ethnic groups females Health authority hospital hospitalized COVID-19 patient hospitalized patients In-hospital death in-hospital mortality increase indicated lower mortality male medical condition Medical conditions Mortality mortality risk nonpharmaceutical intervention occurred omicron pandemic Patient patients hospitalized Period proportion public health Racial reported risk United States variant variant of SARS-CoV-2 virus [DOI] 10.15585/mmwr.mm7137a4 PMC 바로가기
Broad Impacts of Coronavirus Disease 2019 (COVID-19) Pandemic on Acute Respiratory Infections in China: An Observational StudyObservational Study Published on 2022-08-242022-10-05 Journal: Clinical Infectious Diseases: An Official Publicat [Category] 임상, [키워드] activity Acute respiratory infection Adenovirus analyzed average change changes in children China coronavirus coronavirus disease COVID-19 COVID-19 pandemic decrease diagnostic early phase HRV human parainfluenza virus Human rhinovirus Impact impacted Influenza virus lifting métapneumovirus nonpharmaceutical intervention Nonpharmaceutical interventions NPI NPIs observation occurred pandemic reduced remained respiratory respiratory infection respiratory syncytial virus respiratory viral infection respiratory virus resurgence RSV School Sharp suppressed tested viral infections viral pathogen virus while [DOI] 10.1093/cid/ciab942 PMC 바로가기 [Article Type] Observational Study
Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems – United States, August 2022Article Published on 2022-08-192022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] SARS, 변종, 치료제, [키워드] acute illness age Antiviral agents approach Care cause CDC changes in circulating variants conditions COVID-19 COVID-19 illness current death effective effort expand exposure Health high risk Hospitalization Immunity Immunocompromised Impact increase individual Infection information Mask measure Measures medical condition monoclonal antibodies nonpharmaceutical intervention Nonpharmaceutical interventions preexposure prophylaxis Prevent PROTECT public health receive recommendation reduce reduced reducing Respirator risk SARS-CoV-2 symptomatic System therapeutic Treatment United States vaccination Vaccine Vaccines Ventilation virus [DOI] 10.15585/mmwr.mm7133e1 PMC 바로가기
Shift in Clinical Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus B Infections in Korean Children Before and During the COVID-19 Pandemic: A Multicenter Retrospective StudyCOVID-19 팬데믹 이전과 동안 한국 어린이의 인간 파라인플루엔자 바이러스 3형 및 호흡기 세포융합 바이러스 B 감염의 임상 역학 변화: 다기관 후향적 연구Multicenter Study Published on 2022-07-182022-09-12 Journal: Journal of Korean medical science [Category] MERS, 진단, [키워드] analyzed change changes in children circulation clinical Clinical data coronavirus disease COVID-19 COVID-19 pandemic demographic enrolled Epidemic Epidemics epidemiological Epidemiology Hospitalization Human Human Parainfluenza Virus 3 Infection infections investigated Korean Korean children less median age medical record multicenter nonpharmaceutical intervention occurred pandemic Patient remained respiratory respiratory assistance respiratory syncytial virus Retrospective study RSV shift South Korea subject Type university hospital virus [DOI] 10.3346/jkms.2022.37.e215 PMC 바로가기 [Article Type] Multicenter Study
Modeling transmission of SARS-CoV-2 Omicron in China중국 SARS-CoV-2 Omicron 전파 모델링Article Published on 2022-07-012022-09-11 Journal: Nature Medicine [Category] COVID19(2023년), SARS, 변종, 치료법, 치료제, [키워드] Accessibility adopted antiviral therapies antiviral therapy calibrated China Clinical endpoints Coverage COVID-19 Critical care deaths debate Disruption Efficacy Epidemic Factor growth Growth phase Healthcare system Hospitalization hypothetical Immunity implementation individual initial intensive care modeling nonpharmaceutical intervention Nonpharmaceutical interventions omicron outbreak Patient Prevent respond SARS-CoV-2 transmission SARS-CoV-2 variant SARS-CoV-2 variants Shanghai Transmissibility transmission of SARS-CoV-2 vaccination Vaccine vaccine efficacy [DOI] 10.1038/s41591-022-01855-7 PMC 바로가기 [Article Type] Article